Philip Oliver
Director Head, Global Neuroscience Business Development & Licensing, Neuroscience Imed @阿斯利康
Signup · Get unlimited contacts
WORK HISTORY
Director Head, Global Neuroscience Business Development & Licensing, Neuroscience Imed @阿斯利康
Head of Global Neuroscience BD and Licensing for the AstraZeneca Neuroscience iMed, and Head of European Strategic Academic Research Alliances for Medimmune Led the competitive partnering process and the deal team from start to finish for MEDI1814, a potential disease modifying clinical phase Antibody for Alzheimer\'s disease - resulting in the successful co-development collaboration with Eli Lilly announced on December 10th 2016. Led negotiations from start to finish and executed deals on innovative strategic alliance and funding models agreed with- Cambridge University - Framework agreement - Cambridge University Chemical Engineering and Biotech dept, 5 year collaboration - Cambridge University Neuroscience, 3 year collaboration - Sheffield University, 5 year collaboration - Manchester University, 3 year collaboration - Wallenberg Centre for Protein Research, 3 year collaboration covering human secretome and biomanufacturing technology- Global Large Molecule Neuroscience BD and Licensing lead for the AZ Neuroscience iMed- Entrepreneur in Residence at Cambridge University and University College London (UCL)
EDUCATION
Imperial College London
B.Sc. (Hons)
SKILLS
ABOUT PHILIP OLIVER
A dynamic Business Development Director with >25 years industry experience and a…
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.